270 related articles for article (PubMed ID: 10809364)
1. Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer.
Sanz-Ortega J; Steinberg SM; Moro E; Saez M; Lopez JA; Sierra E; Sanz-Esponera J; Merino MJ
Histol Histopathol; 2000 Apr; 15(2):455-62. PubMed ID: 10809364
[TBL] [Abstract][Full Text] [Related]
2. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
3. The role of vascular endothelial growth factor (VEGF) and p53 status for angiogenesis in gastric cancer.
Joo YE; Sohn YH; Joo SY; Lee WS; Min SW; Park CH; Rew JS; Choi SK; Park CS; Kim YJ; Kim SJ
Korean J Intern Med; 2002 Dec; 17(4):211-9. PubMed ID: 12647634
[TBL] [Abstract][Full Text] [Related]
4. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
5. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
Gasparini G; Weidner N; Bevilacqua P; Maluta S; Dalla Palma P; Caffo O; Barbareschi M; Boracchi P; Marubini E; Pozza F
J Clin Oncol; 1994 Mar; 12(3):454-66. PubMed ID: 7509851
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-erbB-2, p53 and c-myc proteins in male breast carcinoma: Comparison with traditional prognostic factors and survival.
Mourão Netto M; Logullo AF; Nonogaki S; Brentani RR; Brentani MM
Braz J Med Biol Res; 2001 Jul; 34(7):887-94. PubMed ID: 11449307
[TBL] [Abstract][Full Text] [Related]
8. The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Raţiu I; Vernic C
Rom J Morphol Embryol; 2010; 51(2):249-57. PubMed ID: 20495739
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ
Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
[TBL] [Abstract][Full Text] [Related]
10. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and cell proliferation in the development of gastric carcinomas: associations with c-myc and p53 protein expression.
Ishii HH; Gobé GC; Pan W; Yoneyama J; Ebihara Y
J Gastroenterol Hepatol; 2002 Sep; 17(9):966-72. PubMed ID: 12167117
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.
Jang WI; Yang WI; Lee CI; Kim HS; Song KS; Cho MY; Park JK; Shim YH
J Korean Med Sci; 1993 Aug; 8(4):293-304. PubMed ID: 7911025
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
[TBL] [Abstract][Full Text] [Related]
15. Relationship between HER-2, COX-2, p53 and clinicopathologic features in gastric adenocarcinoma. Do these biomarkers have any prognostic significance?
Ugraş N; Özgün G; Ocakoğlu G; Yerci Ö; Öztürk E
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():176-81. PubMed ID: 25910300
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD24, p21, p53, and c-myc in alpha-fetoprotein-producing gastric cancer: Correlation with clinicopathologic characteristics and survival.
Liu X; Yu H; Cai H; Wang Y
J Surg Oncol; 2014 Jun; 109(8):859-64. PubMed ID: 24619835
[TBL] [Abstract][Full Text] [Related]
17. Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer.
Park JY; Sung JY; Lee J; Park YK; Kim YW; Kim GY; Won KY; Lim SJ
Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):357-365. PubMed ID: 26508473
[TBL] [Abstract][Full Text] [Related]
18. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR.
Schirosi L; Lantuejoul S; Cavazza A; Murer B; Yves Brichon P; Migaldi M; Sartori G; Sgambato A; Rossi G
Am J Surg Pathol; 2008 Nov; 32(11):1627-42. PubMed ID: 18753943
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
[TBL] [Abstract][Full Text] [Related]
20. [Survival of patients with laryngeal cancer and some prognostic factors].
Gryczyński M; Kobos J; Murlewska A; Pietruszewska W
Otolaryngol Pol; 2003; 57(3):329-40. PubMed ID: 14524174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
